Aducanumab: A Deep Dive into BIIB037 and its Impact The medication, initially known as BIIB037, represents a complex effort to address emerging Alzheimer's illness. Designed by Biogen, aducanumab acts by removing https://www.targetmol.com/compound/aducanumab